Tiny Vallon’s attempt at breaking into the big Adderall market just went up in smoke — and so did its stock
Last month, Vallon Pharmaceuticals touted the hope that it could tap into the Adderall market with an ADHD med that deters people from drug abuse …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
